Dr. Kristen Rinn, MD
Claim this profileCancer Care Northwest
Studies Breast Cancer
1 reported clinical trial
3 drugs studied
Area of expertise
1Breast Cancer
Stage III
Stage IV
HER2 positive
Affiliated Hospitals
Clinical Trials Kristen Rinn, MD is currently running
More about Kristen Rinn, MD
Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Kristen Rinn, MD has experience with
- Eribulin
- Trastuzumab
- Tucatinib
Breakdown of trials Kristen Rinn, MD has run
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kristen Rinn, MD specialize in?
Kristen Rinn, MD focuses on Breast Cancer and other conditions. In particular, much of their work with Breast Cancer has involved Stage III patients, or patients who are Stage IV.
Is Kristen Rinn, MD currently recruiting for clinical trials?
Yes, Kristen Rinn, MD is currently recruiting for 1 clinical trial in Spokane Valley Washington. If you're interested in participating, you should apply.
Are there any treatments that Kristen Rinn, MD has studied deeply?
Yes, Kristen Rinn, MD has studied treatments such as Eribulin, Trastuzumab, Tucatinib.
What is the best way to schedule an appointment with Kristen Rinn, MD?
Apply for one of the trials that Kristen Rinn, MD is conducting.
What is the office address of Kristen Rinn, MD?
The office of Kristen Rinn, MD is located at: Cancer Care Northwest, Spokane Valley, Washington 99216 United States. This is the address for their practice at the Cancer Care Northwest.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.